|Articles|February 22, 2009

Pharmaceutical Commerce

  • Pharmaceutical Commerce - January/February 2009

Wolters Kluwer Scores Prescription-Sales Data Contract From BMS

Dataset has ‘exclusive’ source, the ArcLight consortium

In the competition for providing sales data to pharma marketers, Wolters Kluwer Health (Bridgewater, NJ) says that it has won a multi-year contract with Bristol-Myers Squibb. It will deliver HIPAA-compliant sales data from its Source service to BMS for measuring sales force effectiveness and managing its marketing activities. Wolters claims that the Source dataset captures nearly 80% of prescription transactions in the U.S., covering many of the leading retail chain pharmacies. It includes exclusive sources tracing back to the Arclight Systems business, which was acquired by NDCHealth years ago (and in turn, Wolters acquired NDC in 2005). These retailers add 4,100 retail outlets, amounting to 360 million prescriptions annually.

“This is not only a big win for Wolters Kluwer Health, but the fact that Bristol-Myers Squibb selected us after undertaking an objective, thorough evaluation against others in the marketplace demonstrates its confidence in our data,” says David Martin, VP, marketing and business development, Wolters Kluwer Health. “Adding another major pharma player like Bristol-Myers Squibb solidifies our solutions as a clearly competitive offering in the marketplace.” PC


Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.